Ro’ee Gilron is the lead interdisciplinary researcher on combining deep brain stimulation (chronic & adaptive), device based disease tracking and large scale data to drive insights into disease progression and decision support for neurodegenerative disorders. Interface with product & engineering resources internally and with pharma partners, academic researchers and device manufactures externally for both sponsored and original research. Hopes to deliver a future where personalized therapy for treating neurodegenerative disorders is commonplace.
He was a postdoc in the Starr Lab at UCSF. He received his B.S degree in Neuroscience from Brandeis University and completed his PhD in Cognitive Neuroscience from Tel Aviv University (TAU). At TAU he was a member of the Mukamel lab and wrote his thesis on action representation using neuroimaging. He conducted research in the epilepsy monitoring unit with Itzhak Fried where he fell in love with clinical research. He is specifically interested in the mechanisms underlying the therapeutic benefits of deep brain stimulation for movement disorders. He is currently developing adaptive DBS for the control of tremor, studying the factors underlying the variability of chronic long-term recordings from DBS and developing software for the next generation of DBS devices coming to the lab.